Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment

Date
2015
Author
Eralp, Yesim
Onder, Semen
Yavuz, Ekrem
Karanlik, Hasan
Tambas, Makbule
Aydiner, Adnan
Sen, Fatma
Saip, Pinar
Kucucuk, Seden
Muslumanoglu, Mahmut
Fayda, Merdan
Ciftci, Rumeysa
Igci, Abdullah
Metadata
Show full item record
Abstract
Metaplastic breast carcinoma (MBC) differs from classic invasive ductal carcinomas regarding incidence, pathogenesis, and prognosis. The purpose of this study was to compare patients with MBC with clinicopathologic and treatment-matched patients with triple-negative breast carcinoma (TNBC) in terms of response to treatment, progression, and survival.
URI
http://hdl.handle.net/20.500.12627/128001
https://doi.org/10.1097/md.0000000000002341
Collections